3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
17
Colorectal Neoplasms
17
Non-Muscle Invasive Bladder Neoplasms
10
Neoplasm Metastasis
10
Stomach Neoplasms
9
Appendiceal Neoplasms
9
Anus Neoplasms
9
Peritoneal Neoplasms
8
Carcinoma, Hepatocellular
8
Pancreatic Neoplasms
5
Liver Neoplasms
4
Colonic Neoplasms
4
Pseudomyxoma Peritonei
3
Carcinoma, Transitional Cell
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urothelial Carcinoma Ureter
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Interventions
Cyclophosphamide
115
Dexamethasone
70
fludarabine phosphate
57
Cytarabine
56
fludarabine
52
Rituximab
51
Peripheral Blood Stem Cell Transplantation
40
Etoposide
40
Gemcitabine
39
Lenalidomide
38
pembrolizumab
33
Radiotherapy
33
Busulfan
33
Filgrastim
32
Carboplatin
31
Methotrexate
30
Cyclosporine
29
Cisplatin
29
Bortezomib
29
Mycophenolic Acid
28
Melphalan
28
venetoclax
27
Paclitaxel
26
Whole-Body Irradiation
24
Antilymphocyte Serum
23
Temozolomide
22
Granulocyte Colony-Stimulating Factor
20
Calcium Dobesilate
20
Bevacizumab
20
Tacrolimus
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Recurrence
×
Mitomycin
×
Clear all
NCT06781879
2025-10-03
COBRA-NMIBC
Aarhus University Hospital
Phase 4
Recruiting
272 enrolled